JPH056559B2 - - Google Patents
Info
- Publication number
- JPH056559B2 JPH056559B2 JP58039146A JP3914683A JPH056559B2 JP H056559 B2 JPH056559 B2 JP H056559B2 JP 58039146 A JP58039146 A JP 58039146A JP 3914683 A JP3914683 A JP 3914683A JP H056559 B2 JPH056559 B2 JP H056559B2
- Authority
- JP
- Japan
- Prior art keywords
- csf
- stability
- stable
- inhibitor
- inactivated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003112 inhibitor Substances 0.000 claims description 12
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 238000002523 gelfiltration Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 102000016911 Deoxyribonucleases Human genes 0.000 claims description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 claims description 2
- 108010059712 Pronase Proteins 0.000 claims description 2
- 102000006382 Ribonucleases Human genes 0.000 claims description 2
- 108010083644 Ribonucleases Proteins 0.000 claims description 2
- 108090000631 Trypsin Proteins 0.000 claims description 2
- 102000004142 Trypsin Human genes 0.000 claims description 2
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 claims description 2
- 239000012588 trypsin Substances 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 20
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 208000024770 Thyroid neoplasm Diseases 0.000 description 2
- 210000002798 bone marrow cell Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 201000002510 thyroid cancer Diseases 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010038061 Chymotrypsinogen Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 208000033781 Thyroid carcinoma Diseases 0.000 description 1
- 239000000063 antileukemic agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000013077 thyroid gland carcinoma Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58039146A JPS59166089A (ja) | 1983-03-11 | 1983-03-11 | Ｃｓｆ抑制物質 |
| EP84102620A EP0118908A3 (en) | 1983-03-11 | 1984-03-09 | Csf inhibitory substance |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58039146A JPS59166089A (ja) | 1983-03-11 | 1983-03-11 | Ｃｓｆ抑制物質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59166089A JPS59166089A (ja) | 1984-09-19 |
| JPH056559B2 true JPH056559B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-01-26 |
Family
ID=12544964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58039146A Granted JPS59166089A (ja) | 1983-03-11 | 1983-03-11 | Ｃｓｆ抑制物質 |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP0118908A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
| JP (1) | JPS59166089A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
-
1983
- 1983-03-11 JP JP58039146A patent/JPS59166089A/ja active Granted
-
1984
- 1984-03-09 EP EP84102620A patent/EP0118908A3/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP0118908A3 (en) | 1987-05-06 |
| JPS59166089A (ja) | 1984-09-19 |
| EP0118908A2 (en) | 1984-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saklatvala et al. | Purification to homogeneity of pig leucocyte catabolin, a protein that causes cartilage resorption in vitro | |
| Mizel | Studies on the purification and structure-function relationships of murine lymphocyte activating factor (interleukin 1) | |
| JP2562192B2 (ja) | 血清アルブミンの純化方法 | |
| JP2509407B2 (ja) | 生物学的に活性な化合物の単離方法 | |
| HU196832B (en) | Process for separating plasma proteins from cell cultures | |
| JPH0381290A (ja) | 精製されたアルブミン溶液の製造方法 | |
| JPH05500602A (ja) | 微生物学的に生成されたキモシンの回収方法 | |
| Chaga et al. | Isolation and characterization of catalase from Penicillium chrysogenum | |
| Lappin et al. | Monocyte C1‐inhibitor synthesis in patients with C1‐inhibitor deficiency | |
| JPH056559B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| Prydz | Studtes on Proconvertin (Factor VII) II. Purification | |
| Krystal et al. | CM Affi‐Gel Blue chromatography of human urine: a simple one‐step procedure for obtaining erythropoietin suitable for in vitro erythropoietic progenitor assays | |
| Echetebu et al. | Multiple forms of human y-glutamyltransferase | |
| Makonnen et al. | Purification of an extracellular proteinase from Penicillium notatum | |
| Larsson et al. | Characterization of a human mitogenic factor (MF) released by phytohemagglutinin-activated lymphocytes | |
| JPH022390A (ja) | 新規なヒト顆粒球マクロファージコロニー刺激因子 | |
| JPS62244441A (ja) | 抗体固定化担体 | |
| JPS6226226A (ja) | 抗腫瘍性ポリペプチド | |
| RU2048521C1 (ru) | Способ получения полипептида со свойствами лимфотоксина человека | |
| US7365173B2 (en) | Method for the production of pure virally inactivated butyrylcholinesterase | |
| JP2861655B2 (ja) | ヒト尿性トリプシンインヒビター含有液状製剤及びその製造方法 | |
| Mazitsos et al. | Designed chimaeric galactosyl–mimodye ligands for the purification of Pseudomonas fluorescens β-galactose dehydrogenase | |
| JPH0361440B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| Slavik et al. | [101] Purification of thymidylate synthetase from enzyme-poor sources by affinity chromatography | |
| SU767121A1 (ru) | Способ выделени и очистки трипсина и химотрипсина |